Litcius/Paper detail

974MO 5-year update from KEYNOTE-407: Pembrolizumab plus chemotherapy in squamous non-small cell lung cancer (NSCLC)

Samantha Novello, Dariusz M. Kowalski, Alexander Luft, M. Gumus, David Vicente Baz, Julien Mazières, Jerónimo Rodríguez Cid, Ali Tafreshi, Y. Cheng, K.H. Lee, Alexander Golf, S. Sugawara, Andrew Robinson, B. Halmos, E. Jensen, Paul Schwarzenberger, M. Catherine Pietanza, L. Paz-Ares

2022Annals of Oncology16 citationsDOI

Topics & Concepts

MedicinePlaceboInternal medicinePopulationPembrolizumabOncologyLung cancerCancerAlternative medicineImmunotherapyEnvironmental healthPathologyCancer Immunotherapy and BiomarkersLung Cancer Research StudiesBrain Metastases and Treatment
974MO 5-year update from KEYNOTE-407: Pembrolizumab plus chemotherapy in squamous non-small cell lung cancer (NSCLC) | Litcius